These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3411295)

  • 1. Evaluation of a novel Bayesian method for individualizing theophylline dosage.
    Stein U; Oellerich M; Sybrecht GW; Schneider B
    J Clin Chem Clin Biochem; 1988 Jun; 26(6):405-14. PubMed ID: 3411295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1989 Feb; 27(2):215-21. PubMed ID: 2713215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.
    Chrystyn H; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1987 Sep; 24(3):301-7. PubMed ID: 3663446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three theophylline dosing methods in pediatric patients.
    Godley PJ; Karboski JA; Godley SE; Edwards GA; Moore ES; Sagraves R
    DICP; 1991 Feb; 25(2):179-85. PubMed ID: 2058190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method.
    Wilkens JH; Neuenkirchen H; Sybrecht GW; Oellerich M
    Eur J Clin Pharmacol; 1984; 26(4):491-8. PubMed ID: 6734708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The accuracy and stability of Bayesian theophylline predictions.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Ther Drug Monit; 1988; 10(3):299-305. PubMed ID: 3176107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.
    Hurley SF; McNeil JJ
    Clin Pharmacokinet; 1988 May; 14(5):311-20. PubMed ID: 3396259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
    Lacarelle B; Pisano P; Gauthier T; Villard PH; Guder F; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):127-30. PubMed ID: 7927851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
    Karlsson S; Lührmann B; Bahner ML; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies.
    el Desoky E; Meinshausen J; Bühl K; Engel G; Harings-Kaim A; Drewelow B; Klotz U
    Ther Drug Monit; 1993 Aug; 15(4):281-8. PubMed ID: 8236362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of Bayesian microcomputer predictions of theophylline concentrations in newborn infants.
    Murphy MG; Peck CC; Merenstein GB; Rodden D
    Ther Drug Monit; 1990 Jan; 12(1):47-53. PubMed ID: 2305421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.
    Milavetz G; Vaughan LM; Weinberger MM; Harris JB; Mullenix TA
    J Allergy Clin Immunol; 1987 Nov; 80(5):723-9. PubMed ID: 3680816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs direct pharmacokinetic calculations.
    el Desoky E; Ghazal MH; Mohamed MA; Klotz U
    Jpn J Pharmacol; 1997 Sep; 75(1):13-20. PubMed ID: 9334881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.